An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer

Published:2024-01-02 Issue:1 Volume:25 Page:79-90
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Mahadevia Himil¹²,Uson Junior Pedro Luiz Serrano³⁴,Wang Jing²^ORCID,Borad Mitesh⁴,Babiker Hani²

Affiliation:

1. Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA

2. Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA

3. Department of Internal Medicine, Division of Hematology-Oncology, Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil

4. Department of Internal Medicine, Division of Hematology-Oncology, Mayo Clinic Arizona, Phoenix, AZ, USA

Funder

No funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2304125

Reference91 articles.

1. Cancer immunotherapy using checkpoint blockade

2. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations

3. The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application

4. Anti-cancer vaccines - a one-hit wonder?;Liu JK.;Yale J Biol Med,2014

5. Adoptive Cell Transfer Therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP